LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Ma, Li-Ying"
  2. AU="Corral, Esther"
  3. AU="Ren, Can-Xia"
  4. AU="Shrestha, Lok Bahadur"
  5. AU="Bogert, N V"
  6. AU="Goswami, Sreetosh"
  7. AU="Saraiva, A A F"
  8. AU=Wickenden Julie A
  9. AU="Darbes, Lynae A"
  10. AU="Ostermann, Philipp"
  11. AU="Qiu, Y Z"
  12. AU="Luo, Yue-Jia"
  13. AU="Tamandl, Dietmar" AU="Tamandl, Dietmar"
  14. AU="Holzer, Timothy R"
  15. AU="Zhou, C L"
  16. AU="Lomax, Tony"

Suchergebnis

Treffer 1 - 10 von insgesamt 72

Suchoptionen

  1. Artikel ; Online: Phenotypic variability in two female siblings with oocyte maturation arrest due to a TUBB8 variant.

    Dou, Qian / Xu, HongEn / Ma, LiYing / Tan, Li / Tang, WenXue

    BMC medical genomics

    2023  Band 16, Heft 1, Seite(n) 271

    Abstract: Tubulin beta-8 (TUBB8) is expressed exclusively in the oocyte and early embryo, encoding a beta-tubulin polypeptide that participates in the assembly of microtubules. TUBB8 was first attributed to being responsible for oocyte MI arrest. Further studies ... ...

    Abstract Tubulin beta-8 (TUBB8) is expressed exclusively in the oocyte and early embryo, encoding a beta-tubulin polypeptide that participates in the assembly of microtubules. TUBB8 was first attributed to being responsible for oocyte MI arrest. Further studies have demonstrated that patients with different pathogenic variants have variable phenotypes. We report a TUBB8 variant (c.10 A > C) in two siblings who presented different clinical features of primary infertility. The younger sister showed severe oocyte maturation arrest with abnormal morphology, whereas a few mature oocytes and zygotes could be retrieved from the older sister, but no embryo was available for transfer. This variant was previously reported without in vitro functional assays. In the present study, RT‒qPCR and western blot analyses revealed that c.10 A > C reduces TUBB8 mRNA and protein levels; however, immunofluorescence demonstrated that this variant does not change the localization of the protein. These findings confirm the pathogenicity of the c.10 A > C variant and support the relationship between the variant and phenotype in the patients.
    Mesh-Begriff(e) Female ; Humans ; Biological Variation, Population ; Infertility, Female/genetics ; Oocytes/metabolism ; Oocytes/pathology ; Siblings ; Tubulin/genetics ; Tubulin/metabolism
    Chemische Substanzen TUBB8 protein, human ; Tubulin
    Sprache Englisch
    Erscheinungsdatum 2023-10-30
    Erscheinungsland England
    Dokumenttyp Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2411865-5
    ISSN 1755-8794 ; 1755-8794
    ISSN (online) 1755-8794
    ISSN 1755-8794
    DOI 10.1186/s12920-023-01712-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: EZH2 serves as a promising therapeutic target for fibrosis.

    Zhang, Qian / Wu, Ya-Xi / Yu, Xiao-Qian / Zhang, Bao-Yin / Ma, Li-Ying

    Bioorganic chemistry

    2023  Band 137, Seite(n) 106578

    Abstract: Fibrosis affects the function of many organs and tissues, and its persistent development can lead to tissue sclerosis and cancer, even leading to death further. Recent studies suggested that enhancer of zeste homolog 2 (EZH2), a major regulator of ... ...

    Abstract Fibrosis affects the function of many organs and tissues, and its persistent development can lead to tissue sclerosis and cancer, even leading to death further. Recent studies suggested that enhancer of zeste homolog 2 (EZH2), a major regulator of epigenetic repression, played an important role in the occurrence and development of fibrosis through gene silencing or transcriptional activation. As the most studied and powerful pro-fibrotic cytokine closely related to EZH2, TGF-β1 was primarily involved in the regulation of fibrosis along with the typical Smads and non-Smads signaling pathways. In addition, EZH2 inhibitors demonstrated inhibitory effects in several types of fibrosis. This review summarized the relationship underlying the action of EZH2, TGF-β1/Smads, and TGF-β1/non-Smads with fibrosis and described the research progress of EZH2 inhibitors in the treatment of fibrosis.
    Mesh-Begriff(e) Humans ; Transforming Growth Factor beta1/metabolism ; Enhancer of Zeste Homolog 2 Protein/genetics ; Enhancer of Zeste Homolog 2 Protein/metabolism ; Fibrosis ; Signal Transduction ; Transcriptional Activation
    Chemische Substanzen Transforming Growth Factor beta1 ; Enhancer of Zeste Homolog 2 Protein (EC 2.1.1.43) ; EZH2 protein, human (EC 2.1.1.43)
    Sprache Englisch
    Erscheinungsdatum 2023-05-03
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 120080-x
    ISSN 1090-2120 ; 0045-2068
    ISSN (online) 1090-2120
    ISSN 0045-2068
    DOI 10.1016/j.bioorg.2023.106578
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment.

    Yang, Fei-Fei / Hu, Ting / Liu, Jian-Quan / Yu, Xiao-Qian / Ma, Li-Ying

    European journal of medicinal chemistry

    2022  Band 245, Heft Pt 2, Seite(n) 114920

    Abstract: Bone marrow transplantation is regarded as the most effective immunotherapy for hematologic cancer, but it generally faces difficulties in matching. Aberrant expression of histone deacetylases (HDACs) is closely related to the occurrence and development ... ...

    Abstract Bone marrow transplantation is regarded as the most effective immunotherapy for hematologic cancer, but it generally faces difficulties in matching. Aberrant expression of histone deacetylases (HDACs) is closely related to the occurrence and development of hematological cancer. Recent studies suggested that HDACs might play a critical role in initiating anti-cancer immune response or enhancing anti-cancer immunotherapy. Besides, combining HDAC inhibition and immunotherapy could prevent immunotherapy resistance in some degree and reach an extended treatment window. This review summarized the relationship between HDACs and immune and described the current understanding of HDACs in immunotherapy for hematologic cancer.
    Mesh-Begriff(e) Humans ; Histone Deacetylases ; Hematologic Neoplasms/drug therapy ; Immunotherapy
    Chemische Substanzen Histone Deacetylases (EC 3.5.1.98)
    Sprache Englisch
    Erscheinungsdatum 2022-11-13
    Erscheinungsland France
    Dokumenttyp Review ; Journal Article
    ZDB-ID 188597-2
    ISSN 1768-3254 ; 0009-4374 ; 0223-5234
    ISSN (online) 1768-3254
    ISSN 0009-4374 ; 0223-5234
    DOI 10.1016/j.ejmech.2022.114920
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy.

    Dou, Qian / Ma, Li-Ying / Li, Peng-Fen / Xu, Xiao-Ting / Yu, Guo / Zhang, Dan / Xiang, Yun-Gai / Tan, Li

    Scientific reports

    2023  Band 13, Heft 1, Seite(n) 5978

    Abstract: There are many reports on clinical pregnancy outcomes in polycystic ovary syndrome (PCOS) patients receiving vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), but little research about abortion has been done and there is a debate on ... ...

    Abstract There are many reports on clinical pregnancy outcomes in polycystic ovary syndrome (PCOS) patients receiving vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), but little research about abortion has been done and there is a debate on whether the abortion risk increases in PCOS patients receiving IVF/ICSI. Therefore, the aim of this study was to investigated the abortion in PCOS patients. Clinical data of 12055 IVF/ICSI fresh cycles performed in our hospital from January 2015 to December 2020 were collected. Based on the Rotterdam diagnostic criteria of PCOS and after propensity score matching (PSM) for baseline data of clinical pregnancy cycles, matched 599 PCOS (PCOS group) and Non-PCOS (non-PCOS group) cycles were obtained. Abortion and abortion-related outcomes were compared between the two groups. Risk factors for late abortion in twins were analyzed using binary Logistics regression. Post-PSM data showed that the late abortion rate was significantly higher in the PCOS group than in the non-PCOS group only in twin pregnancy (9.50% vs. 3.96%, OR: 2.55, 95%CI 1.10-5.89). There were no statistical differences in other pregnancy outcomes. The etiological distribution for late abortion were not statistically different between the two groups in both singletons and twins. Logistics regression indicated that PCOS and obesity [pregnancy-assisted body mass index (BMI) ≥ 28] were risk factors for late abortion in twin pregnancy. In twin pregnancy, PCOS and obese patients are more likely to have late abortion. In twin pregnancy, the late abortion risk significantly increased in the PCOS patients as compared with non-PCOS patients (OR: 2.59, 95%CI 1.11-6.03, P < 0.05), as well as in the patients with obesity (BMI ≥ 28) as compared with the patients with normal BMI (OR: 4.17, 95%CI 1.59-10.90, P < 0.05). PCOS does not significantly affect early and overall late abortion rates after IVF/ICSI fresh cycle pregnancy.
    Mesh-Begriff(e) Female ; Pregnancy ; Humans ; Male ; Sperm Injections, Intracytoplasmic ; Polycystic Ovary Syndrome/complications ; Semen ; Pregnancy Outcome ; Fertilization in Vitro ; Abortion, Spontaneous/epidemiology ; Abortion, Spontaneous/etiology ; Pregnancy Rate ; Abortion, Induced ; Obesity/complications ; Retrospective Studies
    Sprache Englisch
    Erscheinungsdatum 2023-04-12
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-32988-5
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Targeting cullin neddylation for cancer and fibrotic diseases.

    He, Zhang-Xu / Yang, Wei-Guang / Zengyangzong, Dan / Gao, Ge / Zhang, Qian / Liu, Hong-Min / Zhao, Wen / Ma, Li-Ying

    Theranostics

    2023  Band 13, Heft 14, Seite(n) 5017–5056

    Abstract: Protein neddylation is a post-translational modification, and its best recognized substrates are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs). Given that most neddylation pathway proteins are overactivated in ... ...

    Abstract Protein neddylation is a post-translational modification, and its best recognized substrates are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs). Given that most neddylation pathway proteins are overactivated in different cancers and fibrotic diseases, targeting neddylation becomes an emerging approach for the treatment of these diseases. To date, numerous neddylation inhibitors have been developed, of which MLN4924 has entered phase I/II/III clinical trials for cancer treatment, such as acute myeloid leukemia, melanoma, lymphoma and solid tumors. Here, we systematically describe the structures and biological functions of the critical enzymes in neddylation, highlight the medicinal chemistry advances in the development of neddylation inhibitors and propose the perspectives concerning targeting neddylation for cancer and fibrotic diseases.
    Mesh-Begriff(e) Humans ; Cullin Proteins/metabolism ; NEDD8 Protein/metabolism ; Neoplasms/drug therapy ; Neoplasms/pathology ; Lymphoma ; Protein Processing, Post-Translational
    Chemische Substanzen Cullin Proteins ; NEDD8 Protein
    Sprache Englisch
    Erscheinungsdatum 2023-09-04
    Erscheinungsland Australia
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592097-2
    ISSN 1838-7640 ; 1838-7640
    ISSN (online) 1838-7640
    ISSN 1838-7640
    DOI 10.7150/thno.78876
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications.

    Yang, Fei-Fei / Xu, Xue-Li / Hu, Ting / Liu, Jian-Quan / Zhou, Jin-Zhu / Ma, Li-Ying / Liu, Hong-Min

    Journal of medicinal chemistry

    2023  Band 66, Heft 7, Seite(n) 4275–4293

    Abstract: Chemotherapy, targeted therapy, and immunotherapy are effective against most tumors, but drug resistance remains a barrier to successful treatment. Lysine-specific demethylase 1 (LSD1), a member of histone demethylation modifications, can regulate ... ...

    Abstract Chemotherapy, targeted therapy, and immunotherapy are effective against most tumors, but drug resistance remains a barrier to successful treatment. Lysine-specific demethylase 1 (LSD1), a member of histone demethylation modifications, can regulate invasion, metastasis, apoptosis, and immune escape of tumor cells, which are associated with tumorigenesis and tumor progression. Recent studies suggest that LSD1 ablation regulates resensitivity of tumor cells to anticarcinogens containing immune checkpoint inhibitors (ICIs) via multiple upstream and downstream pathways. In this review, we describe the recent findings about LSD1 biology and its role in the development and progression of cancer drug resistance. Further, we summarize LSD1 inhibitors that have a reversal or resensitive effect on drug resistance and discuss the possibility of targeting LSD1 in combination with other agents to surmount resistance.
    Mesh-Begriff(e) Humans ; Drug Resistance ; Drug Resistance, Neoplasm/genetics ; Histone Demethylases/antagonists & inhibitors ; Histone Demethylases/metabolism ; Immunotherapy ; Neoplasms/drug therapy ; Neoplasms/metabolism
    Chemische Substanzen Histone Demethylases (EC 1.14.11.-) ; KDM1A protein, human (EC 1.5.-)
    Sprache Englisch
    Erscheinungsdatum 2023-04-04
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.2c01527
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: [Influencing Factors of Pregnancy Outcome of

    Ma, Li-Ying / Xu, Xiao-Ting / Dou, Qian / Zhao, Dong-Mei / Xiang, Yun-Gai / Li, Peng-Fen / Tan, Li

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

    2022  Band 53, Heft 1, Seite(n) 133–136

    Abstract: Objective: To analyze the effect of factors relevant to blastocyst transfer on the pregnancy outcome of : Methods: The clinical data of 790 pregnant women who underwent IVF-ET in our hospital from July 2015 to July 2020 were retrospectively analyzed. ...

    Abstract Objective: To analyze the effect of factors relevant to blastocyst transfer on the pregnancy outcome of
    Methods: The clinical data of 790 pregnant women who underwent IVF-ET in our hospital from July 2015 to July 2020 were retrospectively analyzed. The pregnancy outcome of blastocysts transferred on day 5 (D5,
    Results: In the D5 group, the biochemical pregnancy rate, clinical pregnancy rate and live birth rate of blastocyst transfer were 69.93%, 64.96%, and 41.84%, respectively, which were significantly higher than those of the D6 group at 50.59%, 45.88%, and 30.59%, respectively. The difference was statistically significant (
    Conclusion: The adverse pregnancy outcomes of IVF-ET were found to be associated with age, duration of infertility, endometrial thickness on the day of to blastocyst transfer, trophoblast cell rating, and blastocyst transfer performed after how many days of embryo development, and multiparity, which should be closely monitored, and effective measures should be adopted accordingly to prevent adverse outcomes of pregnancy.
    Mesh-Begriff(e) Adult ; Blastocyst ; Embryo Transfer ; Female ; Fertilization in Vitro ; Humans ; Pregnancy ; Pregnancy Outcome ; Pregnancy Rate ; Retrospective Studies
    Sprache Chinesisch
    Erscheinungsdatum 2022-02-11
    Erscheinungsland China
    Dokumenttyp Journal Article
    ZDB-ID 2106840-9
    ISSN 1672-173X
    ISSN 1672-173X
    DOI 10.12182/20220160205
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Acupuncture in treating obesity combined with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled clinical trials.

    Wang, Ying / Xu, Guang-Nan / Wan, Ren-Hong / Zhou, Xin / Ma, Li-Ying / Liu, Bing / Zhang, Yu-Yan / Zhou, Liang

    Complementary therapies in clinical practice

    2022  Band 49, Seite(n) 101658

    Abstract: Background: and purpose: Most type 2 diabetes mellitus (T2DM) patients are accompanied by overweight or obesity, and it is difficult to concurrently solve these two issues with conventional treatment regimens without experiencing adverse effects. While ... ...

    Abstract Background: and purpose: Most type 2 diabetes mellitus (T2DM) patients are accompanied by overweight or obesity, and it is difficult to concurrently solve these two issues with conventional treatment regimens without experiencing adverse effects. While clinical practice demonstrates that acupuncture is beneficial in treating obesity combined with T2DM, there is a lack of evidence-based medicine to support this claim. The study aims to systematically evaluate the efficacy and safety of acupuncture in treating obesity combined with T2DM.
    Methods: By searching eight electronic databases, we collected randomized controlled trials on acupuncture in treating obesity combined with T2DM. Two reviewers independently screened the literature, extracted the data, and assessed the risk of bias in the included studies. Meta-analysis was then performed using RevMan 5.4 software.
    Results: A total of 13 randomized controlled trials (RCTs) involving 993 patients were eventually included. Meta-analysis results demonstrated the effective rate of clinical symptoms: [RR = 1.19, 95% CI: 1.11, 1.28, P < 0.00001]; body mass index: [MD = -2.11, 95% CI: -2.56, -1.66, P < 0.00001]; fasting plasma glucose: [MD = -1.09, 95% CI: -1.60, -0.59, P < 0.00001]; haemoglobin A1c: [MD = -0.58, 95% CI: -0.95, -0.20, P = 0.002]; triglyceride: [MD = -0.29, 95% CI: -0.46, -0.11, P = 0.001]; waist circumference: [MD = -5.36, 95% CI: -8.68, -2.05, P = 0.002]; body fat rate: [MD = -3.59, 95% CI: -4.28, -2.90, P < 0.00001].
    Conclusion: Current evidence suggests that acupuncture has advantages in treating obesity combined with T2DM. However, due to low-quality evidence of included research, additional large-sample and high-quality research are required to validate the findings of this study.
    Mesh-Begriff(e) Humans ; Diabetes Mellitus, Type 2/therapy ; Diabetes Mellitus, Type 2/drug therapy ; Obesity/complications ; Obesity/therapy ; Acupuncture Therapy ; Body Mass Index ; Randomized Controlled Trials as Topic
    Sprache Englisch
    Erscheinungsdatum 2022-08-13
    Erscheinungsland England
    Dokumenttyp Meta-Analysis ; Systematic Review ; Journal Article ; Review
    ZDB-ID 2182834-9
    ISSN 1873-6947 ; 1744-3881
    ISSN (online) 1873-6947
    ISSN 1744-3881
    DOI 10.1016/j.ctcp.2022.101658
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives.

    Guo, Wen-Ge / Zhao, Jun-Ru / Li, Min / Hu, Ting / Dan, Zengyangzong / Zhang, Qian / Ma, Li-Ying / Zhang, Sai-Yang / Zhao, Bing

    Bioorganic & medicinal chemistry letters

    2022  Band 76, Seite(n) 129020

    Abstract: In order to find high-efficiency and low-toxic anti-tumor drugs, 29 pyrido[3,4-d]pyrimidine compounds were designed, synthesized and evaluated by MTT assay in vitro. The results presented that most of the compounds had good antitumor activities, among ... ...

    Abstract In order to find high-efficiency and low-toxic anti-tumor drugs, 29 pyrido[3,4-d]pyrimidine compounds were designed, synthesized and evaluated by MTT assay in vitro. The results presented that most of the compounds had good antitumor activities, among which compound 30 had the best anti-tumor activity on MGC803 cells (IC
    Mesh-Begriff(e) Humans ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/pharmacology ; Pyrimidines/chemical synthesis ; Pyrimidines/pharmacology ; Structure-Activity Relationship ; Poly(ADP-ribose) Polymerases/metabolism ; BH3 Interacting Domain Death Agonist Protein/metabolism ; Apoptosis/drug effects ; Cell Line, Tumor
    Chemische Substanzen Antineoplastic Agents ; Pyrimidines ; Poly(ADP-ribose) Polymerases (EC 2.4.2.30) ; BH3 Interacting Domain Death Agonist Protein
    Sprache Englisch
    Erscheinungsdatum 2022-10-08
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2022.129020
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Discovery of 1,3,4-oxadiazole derivatives containing a bisamide moiety as a novel class of potential cardioprotective agents.

    Yang, Fei-Fei / Zhou, Jin-Zhu / Xu, Xue-Li / Hu, Ting / Liu, Jian-Quan / Wu, Ya-Xi / Wei, Bo / Ma, Li-Ying

    European journal of medicinal chemistry

    2022  Band 239, Seite(n) 114526

    Abstract: Myocardial injury is a nonnegligible problem in cardiovascular diseases and cancer therapy. The functional feature of N-containing heterocycles in the cardiovascular field has attracted much attention in recent years. Herein, we discovered a lead ... ...

    Abstract Myocardial injury is a nonnegligible problem in cardiovascular diseases and cancer therapy. The functional feature of N-containing heterocycles in the cardiovascular field has attracted much attention in recent years. Herein, we discovered a lead compound 12a containing 1,3,4-oxadiazole by extensive screening of anticancer derivatives containing nitrogen-heterocycle, which exhibited potential protective activity against oxidative stress in cardiomyocytes. Follow-up structure-activity relationship (SAR) studies also highlighted the role of substitution sites and bisamide moiety in enhancing the protective activity against oxidative stress. Specifically, compound 12d exhibited low cytotoxicity under high concentration and potent myocardial protection against oxidative stress in H9c2 cells. Preliminary mechanistic studies showed compound 12d could decrease the expression of cardiac hypertrophy and oxidative stress-related proteins/genes and reduce mitochondria-mediated cell apoptosis, thereby enhancing the cell vitality of injured cardiomyocytes. In this study, 1,3,4-oxadiazole may represent a novel pharmacophore that possesses potential myocardial protection and provides more choices for future optimization of cardiovascular drugs, especially for the treatment of onco-cardiology.
    Mesh-Begriff(e) Cardiotonic Agents/metabolism ; Cardiotonic Agents/pharmacology ; Myocytes, Cardiac/metabolism ; Oxadiazoles/metabolism ; Oxadiazoles/pharmacology ; Oxidative Stress
    Chemische Substanzen Cardiotonic Agents ; Oxadiazoles ; 1,3,4-oxadiazole (20O2F20OUR)
    Sprache Englisch
    Erscheinungsdatum 2022-06-11
    Erscheinungsland France
    Dokumenttyp Journal Article
    ZDB-ID 188597-2
    ISSN 1768-3254 ; 0009-4374 ; 0223-5234
    ISSN (online) 1768-3254
    ISSN 0009-4374 ; 0223-5234
    DOI 10.1016/j.ejmech.2022.114526
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang